Plasmonic Fluor-enhanced antigen arrays for high-throughput, serological studies of SARS-CoV-2

Authors

Abraham J Qavi, Washington University School of Medicine in St. Louis
Chao Wu, Washington University School of Medicine in St. Louis
Matthew Lloyd, Washington University School of Medicine in St. Louis
Mohammad Mahabub-Uz Zaman, Auragent Bioscience
Jingyi Luan, Auragent Bioscience
Claire Ballman, Washington University School of Medicine in St. Louis
Daisy W Leung, Washington University School of Medicine in St. Louis
Scott L Crick, Auragent Bioscience
Christopher W Farnsworth, Washington University School of Medicine in St. Louis
Gaya K Amarasinghe, Washington University School of Medicine in St. Louis

Journal

ACS Infectious Diseases

Publication Date

8-12-2022

Volume

8

Issue

8

First Page

1468

Last Page

1479

Document Type

Open Access Publication

DOI

10.1021/acsinfecdis.2c00086

Rights and Permissions

Qavi AJ, Wu C, Lloyd M, Zaman MM, Luan J, Ballman C, Leung DW, Crick SL, Farnsworth CW, Amarasinghe GK. Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2. ACS Infect Dis. 2022 Aug 12;8(8):1468-1479. doi: 10.1021/acsinfecdis.2c00086. Copyright © 2022 The Authors. CC-BY-NC-ND

Recommended Citation

Qavi, Abraham J; Wu, Chao; Lloyd, Matthew; Zaman, Mohammad Mahabub-Uz; Luan, Jingyi; Ballman, Claire; Leung, Daisy W; Crick, Scott L; Farnsworth, Christopher W; and Amarasinghe, Gaya K, "Plasmonic Fluor-enhanced antigen arrays for high-throughput, serological studies of SARS-CoV-2." ACS Infectious Diseases. 8, 8. 1468 - 1479. (2022).
https://digitalcommons.wustl.edu/oa_4/15